Dr. Blasberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
Box #52
New York, NY 10065Phone+1 646-888-2211
Education & Training
- University of California (San Francisco)Residency, Neurology, 1972 - 1974
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1968 - 1969
- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1967 - 1968
- Albert Einstein College of MedicineClass of 1967
Certifications & Licensure
- NY State Medical License 1969 - 2022
- MD State Medical License 1971 - 1980
- PA State Medical License 1971 - 1976
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Imaging Brain Tumors With FACBC and Methionine Start of enrollment: 2003 May 13
- [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- 2 citationsLDH-A-Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses.Masahiro Shindo, Masatomo Maeda, Ko Myat, Mayuresh M Mane, Ivan J Cohen
Cancers. 2022-05-06 - 11 citationsGenetic and Drug Inhibition of LDH-A: Effects on Murine Gliomas.Masatomo Maeda, Myat Ko, Mayuresh M Mane, Ivan J Cohen, Masahiro Shindo
Cancers. 2022-05-06 - 8 citationsIncreased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.Ivan J Cohen, Fresia Pareja, Nicholas D Socci, Ronglai Shen, Ashley S Doane
Frontiers in Immunology. 2022-01-01
Journal Articles
- LDH-A Regulates the Tumor Microenvironment via HIF-Signaling and Modulates the Immune ResponseRonald Blasberg, Jason A Koutcher, PLoS One
Grant Support
- Mskcc Center For Molecular Imaging In CancerNational Cancer Institute2006–2011
- Organization And AdministrationNational Cancer Institute2008–2010
- Imaging T Cell Interactions In Adoptive Therapy Of Ebv-Associated MalignanciesNational Cancer Institute2008–2010
- Career Development ProgramNational Cancer Institute2008–2010
- Imaging CoreNational Cancer Institute2006–2010
- Imaging Signaling Changes In Cancer And TreatmentNational Cancer Institute2004–2008
- Imaging Brain Tumors With FacbcNational Cancer Institute2003–2004
- Imaging Transgene Expression In Gene Therapy ProtocolsNational Cancer Institute2002–2004
- Mskcc Center For In Vivo Molecular Imaging In CancerNational Cancer Institute2000–2002
- Core--Quantitative Autoradiographic &Optical ImagingNational Cancer Institute2000–2002
- Core--Mskcc FacilitiesNational Cancer Institute2000–2002
- Core--Molecular Biology &Vector DevelopmentNational Cancer Institute2000–2002
- Core--Imaging FacilityNational Cancer Institute2000–2002
- Core--Development ProjectsNational Cancer Institute2000–2002
- Core--Career Development ProgramNational Cancer Institute2000–2002
- Early Assessment Of Cytostatic Drug ResponseNational Cancer Institute1999–2000
- Imaging Gene Transfer And ExpressionNational Cancer Institute1997–1999
- IUDR Imaging Of Tumor ProliferationNational Cancer Institute1997–1998
- Brain Tumor Imaging With Nonmetabolized Amino AcidsNational Cancer Institute1994–1996
- Imaging Tumor Proliferation With 124i-IododeoxyuridineFogarty International Center1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: